BNP Paribas Exane Issues Positive Forecast for Procter & Gamble (NYSE:PG) Stock Price

Procter & Gamble (NYSE:PG) had its price objective raised by equities researchers at BNP Paribas Exane from $177.00 to $189.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. BNP Paribas Exane‘s price target suggests a potential upside of 17.01% from the stock’s previous close.

Other analysts have also recently issued research reports about the stock. Evercore raised shares of Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a research note on Tuesday, October 6th. BMO Capital Markets upped their price objective on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a report on Monday, June 29th. UBS Group set a $166.00 price objective on Procter & Gamble in a research report on Friday. Barclays raised their target price on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Finally, Citigroup upped their price target on Procter & Gamble from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, October 9th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $167.00.

Procter & Gamble Trading Down 2.5%

Shares of NYSE PG traded down $4.07 during trading on Friday, hitting $161.52. 5,132,319 shares of the company were exchanged, compared to its average volume of 9,740,908. The company has a fifty day moving average price of $148.08 and a 200-day moving average price of $146.99. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. The firm has a market capitalization of $375.17 billion, a PE ratio of 24.37, a P/E/G ratio of 3.90 and a beta of 0.39. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $167.25.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The firm had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. During the same quarter in the prior year, the firm posted $1.99 earnings per share. Procter & Gamble’s quarterly revenue was up 4.0% on a year-over-year basis. As a group, equities research analysts expect that Procter & Gamble will post 6.98 EPS for the current year.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Marc Pritchard sold 4,030 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the sale, the insider owned 187,001 shares of the company’s stock, valued at $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of the firm’s stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $344,310.46. Following the transaction, the insider owned 30,730 shares of the company’s stock, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 15,135 shares of company stock worth $2,189,970 in the last three months. Company insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Several large investors have recently added to or reduced their stakes in PG. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of Procter & Gamble during the second quarter worth $26,000. Montgomery Financial Services LLC purchased a new position in Procter & Gamble in the second quarter valued at $28,000. Paladin Partners LLC acquired a new position in Procter & Gamble during the 2nd quarter worth $29,000. Toews Corp ADV acquired a new position in Procter & Gamble during the 2nd quarter worth $37,000. Finally, Evergreen Advisors LLC purchased a new stake in Procter & Gamble during the 1st quarter worth about $37,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G reported fiscal Q1 adjusted earnings of $2.00 per share and revenue of $23.28 billion, exceeding consensus estimates of $1.89 and $22.80 billion, respectively. Revenue increased 4% year over year. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Organic sales growth reaccelerated 4%, with volume contributing 2.4 percentage points. Stronger demand in laundry, home-care and other categories, along with favorable product mix and productivity savings, helped drive the beat.
• Positive Sentiment: Management raised its fiscal 2027 all-in sales-growth outlook, partly reflecting the Thorne acquisition, while maintaining a roughly $86.0 billion-$87.7 billion revenue range and $6.89-$7.11 EPS guidance. P&G raises FY2027 sales outlook
• Positive Sentiment: JPMorgan raised its price target from $162 to $180 and upgraded its stance to overweight, indicating confidence that resilient volumes and improving operating leverage can support further appreciation.
• Neutral Sentiment: TD Cowen increased its target from $150 to $166 but retained a hold rating, signaling limited upside at the current valuation. P&G trades at approximately 24 times earnings, making sustained growth important for additional gains.
• Negative Sentiment: Higher commodity, energy, transportation and fuel costs are expected to pressure fiscal-year profit by roughly $1.4 billion. Analysts also noted that margins remain under strain despite pricing, productivity measures and favorable mix. P&G flags bigger profit hit from commodity costs
• Negative Sentiment: The company’s revenue guidance range remains below the roughly $88.8 billion analyst consensus, and investors still face uncertainty over whether volume growth can offset inflationary costs through the rest of fiscal 2027.

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.